Biomarker Deals and Alliances

1
Biomarker Deals and Alliances
One-Stop Shop for Business Information
2
Summary
The Biomarker Deals and Alliances of 2013 report
provides comprehensive understanding and
unprecedented access to the partnering deals and
agreements entered into by the worlds leading
healthcare companies during 2013. Using these
reports, dealmakers will effectively and
efficiently gain insight into the partnering
activities of the past year. The report series
allows you to view all the partnering and
alliances deals announced worldwide.The initial
chapters of this report provide an orientation of
2013s dealmaking and business activities. Chapte
r 1 provides an overview of the trends in
dealmaking during 2013 covering trends by deal
type, stage of development, technology type and
therapeutic indication.
3
Chapter 2 provides a review of the leading deals
during 2013. Deals are listed by headline value,
signed by bigpharma and bigbiotech, and most
active bigpharma. Where the deal has an agreement
contract published at the SEC a link provides
online access to the contract. Chapter 3
provides a comprehensive listing of the top 50
bigpharma companies with a brief summary followed
by a comprehensive listing of 2013 deals, as well
as contract documents available in the public
domain. Each deal title links via Weblink to an
online version of the deal record and where
available, the contract document, providing easy
access to each contract document on
demand. Chapter 4 provides a comprehensive
directory of all partnering deals announced
during 2013. 
4

• The chapter is organized by company A-Z, stage of
  development at signing, deal type (collaborative
  RD, co-promotion, licensing etc), therapy area
  and technology type. Each deal title links via
  Weblink to an online version of the deal record
  and where available, the contract document,
  providing easy access to each contract document
  on demand.The report series also includes
  numerous tables and figures that illustrate the
  trends and activities in bigpharma partnering and
  dealmaking during 2013.
• In conclusion, this report provides everything a
  prospective dealmaker needs to know about
  partnering in the research, development and
  commercialization of technologies and products
  during 2013.

5
Table Of Content

• Chapter 1 Trends in dealmaking during 2013
• 1.1. Bigpharma dealmaking activity
• 1.2. Partnering by deal type
• Chapter 2 Leading deals during 2013
• 2.1. Introduction
• 2.2. Top deals by value during 2013
• Chapter 3 Bigpharma deals during 2013
• 3.1. Introduction
• 3.2. How to use bigpharma partnering deals
• Chapter 4 Partnering deals directory 2013
• 4.1. Introduction 
• 4.2. Company A-Z 

6

• To know more
• Biomarker Deals and Alliances

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com